Latest News

Search News
Categories
Archives
Celebrating the work of our PhD students

15th October 2021

On 28th September, we held our annual PhD Day – an event that celebrates the work of the postgraduate research students at the Barts Cancer Institute, Queen Mary University of London.

Read more

OPTIMA: Improving treatment for cancer patients through artificial intelligence

12th October 2021

Professors Claude Chelala and Louise Jones from Barts Cancer Institute, Queen Mary University of London, are part of a €21.3 million public-private research programme that will seek to use artificial intelligence to improve care for patients with prostate, breast and lung cancer.

Read more

Location is key: Understanding RNA localisation in cancer

4th October 2021

Dr Faraz Mardakheh has received a project grant from the Medical Research Council, part of UK Research and Innovation, to investigate how RNA localisation becomes dysregulated during cancer progression.

Read more

Mapping the emergence of treatment resistance in leukaemia

28th September 2021

Research led by Barts Cancer Institute, Queen Mary University of London, has identified a new role for a group of cells called adipocytes in contributing to treatment resistance in a type of leukaemia. Published in Nature Communications, the findings broaden the understanding of resistance pathways in blood cancer cells, which is critical for developing novel treatment strategies to improve outcomes for people with leukaemia.

Read more

Tackling blood cancer with Blood Cancer UK

10th September 2021

This Blood Cancer Awareness Month, find out about the Blood Cancer UK-funded research projects currently underway at the Barts Cancer Institute, which span from looking at the specific genetic changes that drive blood cancer development, to identifying new treatment strategies to improve the outcomes for patients.

Read more

BCI researcher receives UKRI Future Leaders Fellowship Award

9th September 2021

Dr Benjamin Werner from Barts Cancer Institute, Queen Mary University of London, is one of the next generation of UK science leaders to receive funding through UK Research and Innovation’s (UKRI) Future Leaders Fellowships scheme. Dr Werner will receive an award of approximately £1.4 million, which will support a research project looking at the evolutionary dynamics of circular extra-chromosomal DNA (ecDNA) in human cancers.

Read more

Search News
Categories
Archives